Seeking Alpha

Shares of Compugen (CGEN) move up 6.9% in premarket trading after the firm announces that its...

Shares of Compugen (CGEN) move up 6.9% in premarket trading after the firm announces that its CGEN-15001T cancer drug demonstrates "significant potential" for cancer immunotherapy. The firm says it ran studies using an antibody specifically recognizing CGEN-15001T.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|